Sunday, August 24, 2014 11:45:03 PM
Roche to Acquire InterMune for $74.00/Share in Cash
The Deal:Roche (OTC: RHHBY) and InterMune (NASDAQ: ITMN) announced Sunday that Roche will acquire InterMune for $74.00 per share in cash, for a total transaction value of $8.3 billion. Roche will commence a tender offer no later than August 29, 2014, to acquire all outstanding shares of InterMune common stock, and InterMune will recommend that InterMune's shareholders tender their shares to Roche.
The deal, which was rumored by multiple sources in the past two weeks, has been approved by the boards of both companies, and is expected to close in 2014.
InterMune closed Friday at $53.80, a gain of 1%.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM